Clearstead Advisors, LLC Anika Therapeutics, Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 44 shares of ANIK stock, worth $406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44Holding current value
$406% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIK
# of Institutions
105Shares Held
11.4MCall Options Held
0Put Options Held
0-
Trigran Investments, Inc.2.04MShares$18.8 Million4.01% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA779KShares$7.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX623KShares$5.76 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA589KShares$5.44 Million1.49% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $135M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...